congratulate! Dr. Tang Zan successfully left the Beike Biological Postdoctoral Workstation

July 27, byThe outbound defense meeting of Dr. Tang Zan, a postdoctoral fellow jointly trained by Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences and Shenzhen Beike Biotechnology Co., Ltd., was held in Beike Building.

At the defense meeting, Dr. Tang Zan gave a defense report titled “Umbilical cord mesenchymal stem cells alleviate pulmonary fibrosis through macrophages.” The assessment and review team, headed by Dr. Hu Junyuan and composed of several experts, conducted a professional and all-round assessment of Dr. Tang’s outgoing thesis. They unanimously believed that Dr. Tang’s postdoctoral thesis met the outgoing requirements and agreed to go out.

Dr. Hu Junyuan, Chairman of Beike Biotechnology, made a concluding speech after the review. He pointed out that the Beike Biological Postdoctoral Innovation Practice Base was approved by the Shenzhen Human Resources and Social Security Bureau in 2013 to create a high-end talent training environment for the cell field and promote the integration of industry, academia and research. The successful exit of postdoctoral fellow Tang Zan is a phased result of Beike Biotech’s corporate innovation and development strategy driven by technology and talents. Beike Biotech has reached a new level in cultivating high-level talent capabilities.

——Beike Biology Postdoctoral Innovation Practice Base——

Beike Biotech was approved by the Shenzhen Municipal Human Resources and Social Security Bureau to establish a postdoctoral innovation practice base in 2013. It was one of the 27 “Postdoctoral Innovation Practice Base” units awarded by Shenzhen that year.

The work of the postdoctoral innovation practice base in Shenzhen began in 1995. The main body of the establishment units is high-tech enterprises, and leading companies in various fields are selected. As a leader in subdivided fields, Beike Biotech has built a postdoctoral innovation practice base in the field of cells, demonstrating our scientific research level and ability to transform innovative scientific and technological achievements in the field of biological sciences. In the future, we will continue to recruit and train postdoctoral researchers in accordance with relevant policies and requirements, build a bridge between high-tech talents and enterprises, accelerate the transformation and industrialization of high-tech achievements, and achieve a seamless connection between industry, academia, and research.